Quinlan Paul T's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Sep 21, 2026
- Accession no.
- 0000907654-26-000100
- Filed
- Sep 21, 2026, 4:57 PM ET
- Trade date
- Sep 21, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $936.4K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quinlan Paul TCIK 0001333277 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $7.80 | +$78,000 | 39,995 | Direct | |
| Sep 21, 2026 | Common Stock | SSaleDisposed | −2,900 | $92.37 | −$267,869.81 | 37,095 | Direct | |
| Sep 21, 2026 | Common Stock | SSaleDisposed | −3,832 | $93.32 | −$357,591.89 | 33,263 | Direct | |
| Sep 21, 2026 | Common Stock | SSaleDisposed | −601 | $94.44 | −$56,760 | 32,662 | Direct | |
| Sep 21, 2026 | Common Stock | SSaleDisposed | −2,667 | $95.31 | −$254,195.77 | 29,995 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 79,996 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.